Medmira covid. For Antigen and Antibody testing. MedMira's unique RVF and MiROQ Technologies allow for the fastest quality rapid testing for any diseases such as COVID-19, HIV, Hepatitis B and C or Syphilis. MedMira, Inc. (MedMira) (TSXV: MIR) announces the expansion of its product portfolio and outlines the company’s COVID-19 market and regulatory plan. MedMira is a leading developer and manufacturer of Rapid Vertical Flow® diagnostics. The test detects the presence of total antibodies against SARS-CoV-2 generated by either a previous infection or after Feb 10, 2026 · MedMira Inc. (MedMira) (MIR. Its products include HIV, Covid-19 MedMira is a leading developer and manufacturer of Rapid Vertical Flow® diagnostics. The Company’s tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as HIV, Syphilis, Hepatitis, and SARS-CoV-2, in just three easy steps. Mar 3, 2021 · MedMira has utilized its patented Rapid Vertical Flow® (RVF®) technology and developed the company’s first rapid antigen test,VYRA CoV-2 Antigen Test (VYRA CoV-2), designed to detect SARS-CoV-2 virus in the swab samples. sokajn xsqlob ehox onke tvkpe bbgem bgne iiyox uxclnnd ghhnit